SCHEMBL31716112

SCHEMBL31716112

COc1c(I)cnc2c(Br)cccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 2/20 0.37
▸ MMP9 P14780 2/20 0.37
▸ MMP13 P45452 2/20 0.37
▸ ADAM17 P78536 2/20 0.37
▸ MCL1 Q07820 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ EGFR P00533 1/20 0.35
▸ CLK1 P49759 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ NQO2 P16083 3/20 0.34
▸ POLB P06746 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TNF P01375 2/20 0.33
▸ LITAF Q99732 2/20 0.33
▸ ALOX5AP P20292 1/20 0.33
▸ FEN1 P39748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17128058 1.00 MMP1 (0.37) MMP1MMP9MMP13ADAM17MCL1
SCHEMBL18436625 0.78 CCR1 (0.38) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL17128367 0.76 MMP1 (0.47) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL17127915 0.75 SRC (0.33) NQO2
SCHEMBL17128052 0.75 KDM4E (0.39) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL17128156 0.75 ALDH1A1 (0.44) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL31716247 0.75 KDM4E (0.39) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL31716256 0.73 MMP1 (0.40) MMP1MMP9MMP13ADAM17KDM4E
SCHEMBL31651581 0.73 POLB (0.55) MCL1KDM4EALDH1A1MAPK1SMN1; SMN2
SCHEMBL17127906 0.71 HRH4 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback